MedTrace Logo

Ultrasound Perfusion Imaging After Aneurysmal Subarachnoid Hemorrhage

NCT01537263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2012-04-06

No results posted yet for this study

Summary

The purpose of this study is to examine wether delayed cerebral ischemia can be predicted by ultrasound brain perfusion imaging in patients with aneurysmal subarachnoid hemorrhage (SAH).

Conditions

  • Aneurysmal Subarachnoid Hemorrhage

Interventions

DEVICE

Ultrasound Perfusion Imaging

Sonographic unit Phillips IU 22, 5ml SonoVue ultrasound contrast agent per examination, Duration: 1h

Sponsors & Collaborators

  • Asklepios Kliniken Hamburg GmbH

    lead OTHER

Principal Investigators

  • Günter Seidel, MD, Professor of Neurology · Asklepios Kliniken Hamburg GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01537263 on ClinicalTrials.gov